Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/13786Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Karnaukh, Ella | - |
| dc.contributor.author | Polikov, H. | - |
| dc.contributor.author | Zavgorodniy, A. | - |
| dc.date.accessioned | 2016-09-15T11:39:53Z | - |
| dc.date.available | 2016-09-15T11:39:53Z | - |
| dc.date.issued | 2016-09 | - |
| dc.identifier.citation | Karnaukh E. V. Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile [Electronic resource] / E. V. Karnaukh, H. O. Polikov, A. S. Zavgorodniy // European Student Scientific Journal. – 2016. – № 2. – Access mode: sjes.esrae.ru/ru/26-376. | ru_RU |
| dc.identifier.issn | 2310-3094 | - |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/13786 | - |
| dc.description.abstract | Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b). | ru_RU |
| dc.language.iso | en | ru_RU |
| dc.subject | genetic engineering | ru_RU |
| dc.title | Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile | ru_RU |
| dc.type | Article | ru_RU |
| Appears in Collections: | Наукові праці. Кафедра фармакології та медичної рецептури | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| опубликована англ стаття ESSJ 2016 #2.doc | 1,79 MB | Microsoft Word | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.